146 related articles for article (PubMed ID: 37767766)
1. Effect of kava (Piper methysticum) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial.
Cribb L; Sarris J; Savage KM; Byrne GJ; Metri NJ; Scholey A; Stough C; Bousman CA
Phytother Res; 2023 Dec; 37(12):5897-5903. PubMed ID: 37767766
[TBL] [Abstract][Full Text] [Related]
2. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
Sarris J; Byrne GJ; Bousman CA; Cribb L; Savage KM; Holmes O; Murphy J; Macdonald P; Short A; Nazareth S; Jennings E; Thomas SR; Ogden E; Chamoli S; Scholey A; Stough C
Aust N Z J Psychiatry; 2020 Mar; 54(3):288-297. PubMed ID: 31813230
[TBL] [Abstract][Full Text] [Related]
3. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging Insights: Kava's (
Savage K; Sarris J; Hughes M; Bousman CA; Rossell S; Scholey A; Stough C; Suo C
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960239
[TBL] [Abstract][Full Text] [Related]
5. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
Trials; 2015 Nov; 16():493. PubMed ID: 26527536
[TBL] [Abstract][Full Text] [Related]
6. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
[TBL] [Abstract][Full Text] [Related]
7. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
Sarris J; LaPorte E; Schweitzer I
Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
[TBL] [Abstract][Full Text] [Related]
8. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.
Sarris J; Kavanagh DJ; Byrne G; Bone KM; Adams J; Deed G
Psychopharmacology (Berl); 2009 Aug; 205(3):399-407. PubMed ID: 19430766
[TBL] [Abstract][Full Text] [Related]
9. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
[TBL] [Abstract][Full Text] [Related]
10. Kava (Piper methysticum).
J Soc Integr Oncol; 2009; 7(4):170-2. PubMed ID: 19883532
[No Abstract] [Full Text] [Related]
11. Therapeutic potential of kava in the treatment of anxiety disorders.
Singh YN; Singh NN
CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
[TBL] [Abstract][Full Text] [Related]
12. Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.
Sarris J; Stough C; Teschke R; Wahid ZT; Bousman CA; Murray G; Savage KM; Mouatt P; Ng C; Schweitzer I
Phytother Res; 2013 Nov; 27(11):1723-8. PubMed ID: 23348842
[TBL] [Abstract][Full Text] [Related]
13. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
Thomsen M; Schmidt M
J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled study of Kava kava in generalized anxiety disorder.
Connor KM; Davidson JR
Int Clin Psychopharmacol; 2002 Jul; 17(4):185-8. PubMed ID: 12131602
[TBL] [Abstract][Full Text] [Related]
15. Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice.
Garrett KM; Basmadjian G; Khan IA; Schaneberg BT; Seale TW
Psychopharmacology (Berl); 2003 Oct; 170(1):33-41. PubMed ID: 12845414
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like effects of kava-kava in the elevated plus maze test--a comparison with diazepam.
Rex A; Morgenstern E; Fink H
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):855-60. PubMed ID: 12369257
[TBL] [Abstract][Full Text] [Related]
17. Kava in generalized anxiety disorder: three placebo-controlled trials.
Connor KM; Payne V; Davidson JR
Int Clin Psychopharmacol; 2006 Sep; 21(5):249-53. PubMed ID: 16877894
[TBL] [Abstract][Full Text] [Related]
18. Explanatory attributions of anxiety and recovery in a study of kava.
Abraham KC; Connor KM; Davidson JR
J Altern Complement Med; 2004 Jun; 10(3):556-9. PubMed ID: 15253862
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
Pittler MH; Ernst E
J Clin Psychopharmacol; 2000 Feb; 20(1):84-9. PubMed ID: 10653213
[TBL] [Abstract][Full Text] [Related]
20. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
Sarris J; Kavanagh DJ
J Altern Complement Med; 2009 Aug; 15(8):827-36. PubMed ID: 19614563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
